CME Group's Q3 2021 results showed robust volume growth as clients managed risks amid economic uncertainty. Average daily volume grew 14% year over year, driven by interest rates, energy, and options products. The company also focused on product innovation and strategic execution, including the OSTTRA joint venture.
Average daily volume grew 14% year over year.
Double-digit growth in interest rates, energy and options products.
Non-U.S. volumes increased 13% to 5 million contracts per day.
Delivered 70 new products and solutions, including Micro Treasury futures and new ESG-focused products.
CME Group did not provide specific forward guidance in the provided document.
Visualization of income flow from segment revenue to net income